» Articles » PMID: 12782572

PRL-3 and PRL-1 Promote Cell Migration, Invasion, and Metastasis

Overview
Journal Cancer Res
Specialty Oncology
Date 2003 Jun 5
PMID 12782572
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

We demonstrate here that Chinese hamster ovary cells stably expressing PRL-3, a M(r) 20000 prenylated protein tyrosine phosphatase, or its relative, PRL-1, exhibit enhanced motility and invasive activity. A catalytically inactive PRL-3 mutant has significantly reduced migration-promoting activity. We observe that PRL-3 is associated with diverse membrane structures involved in cell movement. Furthermore, we show that PRL-3- and -1-expressing cells, but not control cells, induce metastatic tumor formation in mice. Thus, our results deliver the first evidence for a causative role of PRL-3 and -1 in promoting cell motility, invasion activity, and metastasis.

Citing Articles

PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity.

Ye Z, Ng C, Liu H, Bao Q, Xu S, Zu D Theranostics. 2024; 14(9):3423-3438.

PMID: 38948056 PMC: 11209707. DOI: 10.7150/thno.93127.


Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody.

Loh A, Thura M, Gupta A, Tan S, Kuan K, Ang K Mol Ther Oncolytics. 2023; 30:153-166.

PMID: 37674627 PMC: 10477756. DOI: 10.1016/j.omto.2023.08.006.


PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types.

Chia P, Ang K, Thura M, Zeng Q Theranostics. 2023; 13(6):1876-1891.

PMID: 37064866 PMC: 10091880. DOI: 10.7150/thno.79265.


Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma.

Li C, Tsai H, Chen Y, Wang C, Lin Y, Chu P J Hepatocell Carcinoma. 2023; 10:123-138.

PMID: 36741246 PMC: 9896975. DOI: 10.2147/JHC.S385238.


PRL stimulates mitotic errors by suppressing kinetochore-localized activation of AMPK during mitosis.

Ryu K, Yoshida A, Funato Y, Yamazaki D, Miki H Cell Struct Funct. 2022; 47(2):75-87.

PMID: 36336348 PMC: 10511051. DOI: 10.1247/csf.22034.